KULBHUSHAN SHARMA

Dr. KULBHUSHAN SHARMA

Department of Clinical Molecular Biology, University of Oslo, 0318 Oslo, Norway
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2016 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
MCMadhuri Chaurasia
Madhuri Chaurasia
ABAnant Narayan Bhatt
Anant Narayan Bhatt
ADAsmita Das
Asmita Das
BDBilikere S Dwarakanath
Bilikere S Dwarakanath
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
Radiation-induced autophagy: mechanisms and consequences. . ???aop.label???. doi: 10.3109/10715762.2015.1129534

28 March 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
STS Tripathi
S Tripathi
JBJ Batra
J Batra
WCW Cao
W Cao
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
JPJ R Patel
J R Patel
SLS K Lal
S K Lal
Apoptosis induction is an antiviral host response, however, influenza A virus (IAV) infection promotes host cell death. The nucleoprotein (NP) of IAV is known to contribute to viral pathogenesis, but its role in virus-induced host cell death was hitherto unknown. We observed that NP contributes to IAV infection induced cell death and heterologous expression of NP alone can induce apoptosis in human airway epithelial cells. The apoptotic effect of IAV NP was significant when compared with other known proapoptotic proteins of IAV. The cell death induced by IAV NP was executed through the intrinsic apoptosis pathway. We screened host cellular factors for those that may be targeted by NP for inducing apoptosis and identified human antiapoptotic protein Clusterin (CLU) as a novel interacting partner. The interaction between IAV NP and CLU was highly conserved and mediated through β-chain of the CLU protein. Also CLU was found to interact specifically with IAV NP and not with any other known apoptosis modulatory protein of IAV. CLU prevents induction of the intrinsic apoptosis pathway by binding to Bax and inhibiting its movement into the mitochondria. We found that the expression of IAV NP reduced the association between CLU and Bax in mammalian cells. Further, we observed that CLU overexpression attenuated NP-induced cell death and had a negative effect on IAV replication. Collectively, these findings indicate a new function for IAV NP in inducing host cell death and suggest a role for the host antiapoptotic protein CLU in this process.

20 March 2019 in Autophagy
Verified
Journal Article
Closed access
MCMadhuri Chaurasia
Madhuri Chaurasia
SGSwapnil Gupta
Swapnil Gupta
ADAsmita Das
Asmita Das
BDBilikere S Dwarakanath
Bilikere S Dwarakanath
ASAnne Simonsen
Anne Simonsen
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
Cellular effects of ionizing radiation include oxidative damage to macromolecules, unfolded protein response (UPR) and metabolic imbalances. Oxidative stress and UPR have been shown to induce macro...

1 February 2014 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
SMShashank Misra
Shashank Misra
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
Cancer is a leading cause of death worldwide. The expression of COX-2 and prostaglandins has not only been associated with various types of cancer but is also directly proportional to their aggressiveness including metastasis. Thus, inhibition of COX-2 activity has been one of the preferred targets for cancer reduction. Broad spectrum inhibition of all forms of COX (using NSAIDs) is associated with various side effects ranging from gastric ulceration to renal problems. Even specific COX-2 inhibitors (COXIBs) are associated with side effects like myocardial infarction. Alternative strategies including siRNA technology are also not very victorious due to their off-target associated problems. Thus, there is an urgent need for the development of strategies where COX-2 activity may be reduced without inducing any side effects. One of the approaches for designing novel inhibitors may be to target various molecules downstream of COX-2. In this review, we have tried to cover the basic biology of COX-2 and its association with different types of cancer. Various generations of COX-2 inhibitors have been covered with their merits and demerits. Possible exploitation of novel targets like EP receptors, mPGES and various other downstream molecules which can be utilized for a better COX-2 signaling inhibition and thus efficient cancer reduction with minimal side effects has been discussed.

15 June 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
STShashank Tripathi
Shashank Tripathi
PRPriya Ranjan
Priya Ranjan
PKPurnima Kumar
Purnima Kumar
RGRebecca Garten
Rebecca Garten
SLSunil K. Lal
Sunil K. Lal
Double-stranded RNA dependent protein kinase (PKR) is a key regulator of the anti-viral innate immune response in mammalian cells. PKR activity is regulated by a 58 kilo Dalton cellular inhibitor (P58IPK), which is present in inactive state as a complex with Hsp40 under normal conditions. In case of influenza A virus (IAV) infection, P58IPK is known to dissociate from Hsp40 and inhibit PKR activation. However the influenza virus component responsible for PKR inhibition through P58IPK activation was hitherto unknown. Human heat shock 40 protein (Hsp40) was identified as an interacting partner of Influenza A virus nucleoprotein (IAV NP) using a yeast two-hybrid screen. This interaction was confirmed by co-immunoprecipitation studies from mammalian cells transfected with IAV NP expressing plasmid. Further, the IAV NP-Hsp40 interaction was validated in mammalian cells infected with various seasonal and pandemic strains of influenza viruses. Cellular localization studies showed that NP and Hsp40 co-localize primarily in the nucleus. During IAV infection in mammalian cells, expression of NP coincided with the dissociation of P58IPK from Hsp40 and decrease PKR phosphorylation. We observed that, plasmid based expression of NP in mammalian cells leads to decrease in PKR phosphorylation. Furthermore, inhibition of NP expression during influenza virus replication led to PKR activation and concomitant increase in eIF2α phosphorylation. Inhibition of NP expression also led to reduced IRF3 phosphorylation, enhanced IFN β production and concomitant reduction of virus replication. Taken together our data suggest that NP is the viral factor responsible for P58IPK activation and subsequent inhibition of PKR-mediated host response during IAV infection. Our findings demonstrate a novel role of IAV NP in inhibiting PKR-mediated anti-viral host response and help us understand P58IPK mediated inhibition of PKR activity during IAV infection.

27 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKULBHUSHAN SHARMA
KULBHUSHAN SHARMA
SÅSara Åkerström
Sara Åkerström
ASAnuj Kumar Sharma
Anuj Kumar Sharma
JOJoe Ong
Joe Ong
STShumein Teow
Shumein Teow
SLSunil K. Lal
Sunil K. Lal
9b is an accessory protein of the SARS-CoV. It is a small protein of 98 amino acids and its structure has been solved recently. 9b is known to localize in the extra-nuclear region and has been postulated to possess a nuclear export signal (NES), however the role of NES in 9b functioning is not well understood. In this report, we demonstrate that 9b in the absence of any nuclear localization signal (NLS) enters the nucleus by passive transport. Using various cell cycle inhibitors, we have shown that the nuclear entry of 9b is independent of the cell cycle. Further, we found that 9b interacts with the cellular protein Crm1 and gets exported out of the nucleus using an active NES. We have also revealed that this NES activity influences the half-life of 9b and affects host cell death. We found that an export signal deficient SARS-CoV 9b protein induces apoptosis in transiently transfected cells and showed elevated caspase-3 activity. Here, we showed that nuclear shuttling of 9b and its interaction with Crm1 are essential for the proper degradation of 9b and blocking the nuclear export of this protein induces apoptosis. This phenomenon may be critical in providing a novel role to the 9b accessory protein of SARS-CoV.